Serum 25-hydroxyvitamin D Concentrations (25OHD)
Conditions
Keywords
Vitamin D, Serum 25-hydroxyvitamin D (25OHD), Dietary supplement, Ethnicity, Immigrant
Brief summary
Insufficient intake of vitamin D is a public health problem, affecting about 40% of the Finnish population in the winter. Vitamin D has a wide range of health effects: in addition to its effect on bone, it is known to affect inflammatory response among other things. The sources of vitamin D are the synthesis in the skin as well as diet and dietary supplements. In Finland and in Northern Europe vitamin D is formed in the skin only from March to October. This alone is not sufficient to cover the need for year-round, because vitamin D storage is used in a few months. During the winter months the only sources of vitamin D are diet and vitamin preparations. Current vitamin D recommendations are usually based on studies in white population. However, there can be a difference in the need of vitamin D and in vitamin D metabolism between different population groups. More research evidence is needed from the northern countries. The aim of this study is to evaluate the vitamin D need in Somali immigrant population and in original Finnish population. The hypothesis is that the Somalis need more vitamin D to exceed the serum 25(OH)D concentration of 50 nmol/L than the original Finnish population.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* woman between 21-66 years of age * belongs to original Finnish population or to Somali immigrant population * healthy (= no disease requiring medication) * lives in the metropolitan area
Exclusion criteria
* pregnant or breastfeeding * has traveled to a sunny destination or destination near the equator during the previous month * plans to travel to a sunny destination or destination near the equator in the next 6 months * has used a tanning bed during the previous month * plans to use a tanning bed in the next 6 months * the subject's blood 25-hydroxy-vitamin D level (25 (OH) D), exceeds 100 nmol / L or is less than 30 nmol / L at baseline in the screening phase.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serum 25-hydroxyvitamin D (25(OH)D) concentrations | Change from baseline in serum 25(OH)D concentration at 3 and 6 months | The effect of ethnicity on the serum 25(OH)D concentration response to vitamin D supplementation will be investigated. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Serum calcium concentration | Change from baseline in serum calcium concentration at 3 and 6 months | Markers of calcium metabolism, which are affected by vitamin D, will be measured |
| Serum parathyroid hormone (PTH) concentration | Change from baseline in serum PTH concentration at 3 and 6 months | Markers of calcium metabolism, which are affected by vitamin D, will be measured |
Other
| Measure | Time frame | Description |
|---|---|---|
| Polymorphisms in genes involved in the transport and metabolism of vitamin D | Baseline | Genomic DNA will be isolated and single nucleotide polymorphisms (SNPs) for key genes involved in vitamin D transport and metabolism will be measured to investigate the ethnic variation in the genes. |
Countries
Finland